RankAlpha logo
Back to Rankings

ACOG

Alpha CognitionD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
Curated Events
1
Active
Recent Headlines
0
New
Recent news sentiment
-
30-day score
Company
-
30-day
Macro
-
30-day
Pulse
-
30-day
Weekly research
-
10-day

Curated events

Materiality
90
earnings
Source
External coverage
Decided
2026-08-13
Alpha Cognition Inc. Reports First Quarter 2026 Financial Results and Provides Operational Update

Positive commercial update for ACOG: Q1 ZUNVEYL revenue reached $3.5 million with 40% sequential growth and bottles dispensed rose 23%, though the $6.5 million net loss and lower cash balance temper the thesis. Verified against the BusinessWire release: https://www.businesswire.com/news/home/20260514615228/en/Alpha-Cognition-Inc.-Reports-First-Quarter-2026-Financial-Results-and-Provides-Operational-Update

Sentiment decomposition

-
30-day score
Company-55%
Macro-30%
Pulse-15%
Weekly research-10-day
Company, Macro, and Pulse form the existing 30-day artifact blend. Weekly research is tracked separately for 10 days and can contribute at most 10% of the sentiment pillar when live mode is enabled.

Recent headlines

No supplemental ticker headlines stored yet

We are still collecting relevant articles for ACOG. Curated events highlight the most material developments impacting this ticker right now.

As of 2026-08-13 • Updated scheduledSource: News desk